Altimmune to Participate at Two Upcoming Investor Conferences

Rhea-AI Summary

Altimmune, Inc. (Nasdaq: ALT) announced its participation in two upcoming investor conferences in June 2022. The events include the Jefferies 2022 Global Healthcare Conference on June 10 at 10:00 am ET and the JMP Securities Life Sciences Conference on June 16 at 9:00 am ET, both held in New York. Interested investors can access the webcast via the company’s website. Altimmune develops novel therapeutics for obesity and liver diseases.

GAITHERSBURG, Md., June 03, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the following investor conferences in June 2022:

• Jefferies 2022 Global Healthcare Conference in New York, NY
  Friday, June 10, 2022
  Fireside chat at 10:00 am Eastern Time

• JMP Securities Life Sciences Conference in New York, NY
  Thursday, June 16, 2022
  Fireside chat at 9:00 am Eastern Time

The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide (ALT-801), is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell™, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Altimmune Investor & Media Contact:

Richard Eisenstadt
Chief Financial Officer
Phone: 240-654-1450
reisenstadt@altimmune.com

FAQ

What events is Altimmune participating in June 2022?

Altimmune will participate in the Jefferies 2022 Global Healthcare Conference on June 10 and the JMP Securities Life Sciences Conference on June 16, 2022.

What is the date and time of Altimmune's fireside chat at the Jefferies conference?

The fireside chat at the Jefferies conference is scheduled for June 10, 2022, at 10:00 am Eastern Time.

What time is Altimmune's fireside chat at the JMP Securities Life Sciences Conference?

Altimmune's fireside chat at the JMP Securities Life Sciences Conference will take place on June 16, 2022, at 9:00 am Eastern Time.

Where can I watch the webcasts of Altimmune's conference presentations?

The webcasts of Altimmune's conference presentations can be accessed on the company's Events section of their website.

What are Altimmune's main product focuses?

Altimmune focuses on developing peptide-based therapeutics for obesity and liver diseases, including the product candidate pemvidutide (ALT-801).